First Look Analysts Research Calls for Thursday, March 16

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Choice Hotels (CHH) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $134

> FedEx (FDX) upgraded to Buy from Hold at Stifel; tgt raised to $222

> Foot Locker (FL) upgraded to Outperform from Market Perform at Telsey Advisory Group; tgt raised to $50

> Intel (INTC) upgraded to Neutral from Negative at Susquehanna; tgt raised to $26

> Jones Lang LaSalle (JLL) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $218

> Mersana Therapeutics (MRSN) upgraded to Overweight from Neutral at JP Morgan; tgt $10

> Motorola Solutions (MSI) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $305

> ORIC Pharmaceuticals (ORIC) upgraded to Outperform from Perform at Oppenheimer; tgt $14

> Qualcomm (QCOM) upgraded to Positive from Neutral at Susquehanna; tgt raised to $140

> Skyworks (SWKS) upgraded to Positive from Neutral at Susquehanna; tgt raised to $135

> Takeda Pharma (TAK) upgraded to Buy from Neutral at BofA Securities; tgt $20

Downgrades:

> Babylon (BBLN) downgraded to Neutral from Buy at BTIG Research

> Esperion Therapeutics (ESPR) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $1.50

> LivePerson (LPSN) downgraded to Neutral from Buy at ROTH MKM; tgt lowered to $6

> Medical Properties Trust (MPW) downgraded to Neutral from Buy at BofA Securities; tgt $10

Others:

> eMagin (EMAN) initiated with a Buy at Ladenburg Thalmann; tgt $3

> lululemon athletica (LULU) initiated with a Sell at Redburn; tgt $257

> NIKE (NKE) initiated with a Sell at Redburn; tgt $100

> Organon (OGN) initiated with an Outperform at Raymond James; tgt $33

> Under Armour (UAA) initiated with a Buy at Redburn; tgt $13.50